Aquarius Surgical Technologies Announces Share Issuance
Aquarius Surgical Technologies Announces Share Issuance
TORONTO, ON / ACCESSWIRE / March 25, 2022 / Aquarius Surgical Technologies Inc. (CSE:ASTI) announces that it has issued 100,000 shares to each of four non-executive directors and to corporate officers, in compensation for services, for a total of 600,000 shares. All shares were issued at a stated price of $0.065 each. The shares were issued pursuant to the prospectus exemption contained in NI 45-106 s. 2.24 and are not subject to any restrictive hold period.
多倫多，on/ACCESSWIRE/2022年3月25日/Aquarius Surgical Technologies Inc.(CSE：ASTI)宣佈已向四名非執行董事和公司高管各發行100,000股，作為對服務的補償，總計600,000股。所有股票的發行價均為每股0.065美元。該等股份乃根據載於NI 45-106第2.24條的招股章程豁免而發行，並不受任何限制性持有期的限制。
About Aquarius Surgical Technologies Inc.
寶瓶座外科技術公司簡介
Aquarius Surgical Technologies is a provider of innovative, minimally invasive medical laser systems and consumables for multiple medical disciplines, principally in the field of urology. Solutions also include clinical education, service, support and maintenance. ASTI is focused on increasing the availability of services for patients, enhancing the quality of patient care, improving operationally efficiencies and reducing total operational costs.
Aquarius Surgical Technologies是一家創新的微創醫療激光系統和耗材的供應商，適用於多個醫學學科，主要是在泌尿外科領域。解決方案還包括臨牀教育、服務、支持和維護。ASTI專注於增加為患者提供的服務，提高患者護理的質量，提高運營效率，並降低總運營成本。
For more information, please contact:
如需更多信息，請聯繫：
Gary Van Nest, co-CEO gary@sinaltainvestments.com
Lorne MacFarlance, CFO lornemac@eastlink.ca ; 902-496-7594
聯席首席執行官Gary@sinaltainvestments.com
CFO lornemac@eastlink.ca；902-496-7594
Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.
加拿大證券交易所及其監管服務提供商(該術語在加拿大證券交易所的政策中定義)均不對本新聞稿的充分性或準確性承擔責任.
SOURCE: Aquarius Surgical Technologies Inc.
資料來源：寶瓶座外科技術公司。